Drug
Permethrin 5%
Permethrin 5% is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
1
33%
Ph early_phase_1
1
33%
Ph phase_3
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
unknown133%
completed133%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingearly_phase_1
Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children
NCT07247630
completedphase_3
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
NCT03236168
unknownphase_4
The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis
NCT03105505
Clinical Trials (3)
Showing 3 of 3 trials
NCT07247630Early Phase 1
Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children
NCT03236168Phase 3
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
NCT03105505Phase 4
The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3